1. Home
  2. OGEN vs IVDA Comparison

OGEN vs IVDA Comparison

Compare OGEN & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • IVDA
  • Stock Information
  • Founded
  • OGEN 1996
  • IVDA 2003
  • Country
  • OGEN United States
  • IVDA United States
  • Employees
  • OGEN N/A
  • IVDA N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • IVDA Computer Software: Prepackaged Software
  • Sector
  • OGEN Health Care
  • IVDA Technology
  • Exchange
  • OGEN Nasdaq
  • IVDA Nasdaq
  • Market Cap
  • OGEN 2.5M
  • IVDA 6.7M
  • IPO Year
  • OGEN N/A
  • IVDA N/A
  • Fundamental
  • Price
  • OGEN $1.39
  • IVDA $2.19
  • Analyst Decision
  • OGEN
  • IVDA
  • Analyst Count
  • OGEN 0
  • IVDA 0
  • Target Price
  • OGEN N/A
  • IVDA N/A
  • AVG Volume (30 Days)
  • OGEN 1.2M
  • IVDA 78.5K
  • Earning Date
  • OGEN 08-08-2025
  • IVDA 08-13-2025
  • Dividend Yield
  • OGEN N/A
  • IVDA N/A
  • EPS Growth
  • OGEN N/A
  • IVDA N/A
  • EPS
  • OGEN N/A
  • IVDA N/A
  • Revenue
  • OGEN N/A
  • IVDA $7,148,449.00
  • Revenue This Year
  • OGEN N/A
  • IVDA $340.48
  • Revenue Next Year
  • OGEN N/A
  • IVDA N/A
  • P/E Ratio
  • OGEN N/A
  • IVDA N/A
  • Revenue Growth
  • OGEN N/A
  • IVDA 54.15
  • 52 Week Low
  • OGEN $1.34
  • IVDA $1.27
  • 52 Week High
  • OGEN $75.60
  • IVDA $8.05
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 26.99
  • IVDA 51.25
  • Support Level
  • OGEN $1.40
  • IVDA $1.76
  • Resistance Level
  • OGEN $1.58
  • IVDA $2.44
  • Average True Range (ATR)
  • OGEN 0.28
  • IVDA 0.18
  • MACD
  • OGEN -0.13
  • IVDA 0.04
  • Stochastic Oscillator
  • OGEN 2.44
  • IVDA 57.53

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: